Anxiolytic and Antidepressant like Profile of Repeatedly administrated Escitalopram in Behavioral Animal Models

Journal Title: Pakistan Journal of Pharmaceutical Research - Year 2017, Vol 3, Issue 1

Abstract

Selective serotonin reuptake inhibitors (SSRIs) were initially introduced as antidepressants, and their potential as anxiolytic has been observed in the treatment of social phobia, post-traumatic stress disorder, and generalized anxiety disorder Escitalopram is therapeutically active S-enantiomer of citalopram. It is a commonly prescribed Selective serotonin reuptake inhibitor (SSRI). SSRIs are the latest generated antidepressants having the selective mechanism of action towards 5-Hydroxytryptamine (Serotonin; 5-HT) without affecting any other unwanted effects on other neurotransmitters. Escitalopram is very selective serotonin reuptake inhibitor; it blocks the serotonin transporters without producing any significant effect on other monoamines transporters. Evidences suggest that escitalopram is efficient in the treatment of major depressive disorder (MDD) and generalized anxiety disorders (GAD). The present study was designed to determine the effects of repeated administration of escitalopram on locomotor activity and anxiolytic behavior of animals in animal model. Rats were administered orally with escitalopram (5 mg/kg) daily for 7 days. This study showed anxiolytic activity produced on repeated administration of drug in light dark transition test. As compared to control animals, activity in activity box was higher and activity in open field was smaller in escitalopram administrated animals. These information support clinical discoveries that escitalopram is a powerful, very much endured SSRI with anxiolytic-like impacts.

Authors and Affiliations

Muhammad Farhan

Keywords

Related Articles

Awareness about Homoeopathy among University students

Homoeopathy is an alternative medical treatment developed in Germany by Dr. Samuel Hahnemann. He proposed two theories about homoeopathy: “Like cures Like” and the “Law of Minimum Dose”. The objective for this study was...

Anxiolytic and Antidepressant like Profile of Repeatedly administrated Escitalopram in Behavioral Animal Models

Selective serotonin reuptake inhibitors (SSRIs) were initially introduced as antidepressants, and their potential as anxiolytic has been observed in the treatment of social phobia, post-traumatic stress disorder, and gen...

Prevalence of end stage renal disease in diabetic obese and hypertensive patients and cardiovascular risk in dialysis patients

Chronic Kidney Disease (CKD) is cause of irreversible deterioration in renal function which leads to end stage renal disease (ESRD). Incidence of end-stage renal disease has increased dramatically during the last 30 year...

CNS depressant activity of Chamomile methanol extract in mice

Matricaria chamomilla L. (Asteraceae) is a well-known plant in most ancient traditional medicine and highly used for the cure of numerous medical disorders, insomnia included. Using a sleep disturbed model, pentobarbital...

Demographic and hematologic pattern of acute myeloid leukemia patients from lower Punjab area of Pakistan

Purpose of this study was to evaluate the demographic and hematologic pattern of acute myeloid leukemia patients from lower Punjab area. Treatment of the acute myeloid leukemia patients is related with the unsatisfactory...

Download PDF file
  • EP ID EP204112
  • DOI 10.22200
  • Views 100
  • Downloads 0

How To Cite

Muhammad Farhan (2017). Anxiolytic and Antidepressant like Profile of Repeatedly administrated Escitalopram in Behavioral Animal Models. Pakistan Journal of Pharmaceutical Research, 3(1), 31-39. https://europub.co.uk/articles/-A-204112